PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CD22 1,591 Target Drug Alemtuzumab (Campath)- FDA 32 1 0.00 -0.98 0.03 0.67
CD22 1,591 Target Target EGF 27,487 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Myelodysplastic Syndrome 7,378 4 0.00 -1.00 0.00 0.60
CD22 1,591 Target Disease Sepsis 64,798 3 0.00 -1.00 0.00 0.53
CD22 1,591 Target Target BTK 1,263 8 0.01 -0.99 0.01 0.68
CD22 1,591 Target Disease Diabetic Retinopathy 14,494 3 0.00 -1.00 0.00 0.57
CD22 1,591 Target Target AGP 2,006 1 0.00 -1.00 0.00 0.59
CD22 1,591 Target Disease Rheumatic Fever 6,356 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Rare Diseases 2,212 1 0.00 -1.00 0.00 0.59
CD22 1,591 Target Disease Psoriasis 26,882 2 0.00 -1.00 0.00 0.54
CD22 1,591 Target Disease Gastritis 17,713 2 0.00 -1.00 0.00 0.55
CD22 1,591 Target Disease Syphilis 20,217 1 0.00 -1.00 0.00 0.53
CD22 1,591 Target Disease Pain 409,851 4 0.00 -1.00 0.00 0.49
CD22 1,591 Target Disease Leukemia 162,805 430 0.03 -0.85 0.27 0.65
CD22 1,591 Target Disease Hemorrhoids 2,290 1 0.00 -1.00 0.00 0.59
CD22 1,591 Target Disease Breast Cancer 173,695 4 0.00 -1.00 0.00 0.51
CD22 1,591 Target Disease Asthma 109,610 4 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Sinusitis 12,330 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Disease Brain Tumors 16,749 1 0.00 -1.00 0.00 0.53
CD22 1,591 Target Disease Down Syndrome 10,290 2 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Muscle Weakness 9,178 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Disease Bacterial Infections 14,248 1 0.00 -1.00 0.00 0.54
CD22 1,591 Target Disease Proteinuria 28,803 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Target Complement Component C1q 167 1 0.00 -1.00 0.01 0.64
CD22 1,591 Target Target BRAF 4,766 3 0.00 -1.00 0.00 0.60
CD22 1,591 Target Disease Lung Cancer 91,416 4 0.00 -1.00 0.00 0.52
CD22 1,591 Target Target CD34 24,598 115 0.02 -0.96 0.07 0.67
CD22 1,591 Target Disease Ankylosing Spondylitis 9,665 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Target Elastase 13,875 3 0.00 -1.00 0.00 0.57
CD22 1,591 Target Disease Hypothyroidism 23,397 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Seizures 66,465 1 0.00 -1.00 0.00 0.50
CD22 1,591 Target Drug Arranon (Nelarabine)- FDA 12 1 0.01 -0.96 0.08 0.68
CD22 1,591 Target Disease Ulcers 45,142 2 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Inflammation 252,734 39 0.00 -0.99 0.02 0.56
CD22 1,591 Target Drug Doxorubicin 28,033 21 0.00 -0.99 0.01 0.61
CD22 1,591 Target Disease Heart Disease 118,291 2 0.00 -1.00 0.00 0.50
CD22 1,591 Target Disease Vertigo 10,084 1 0.00 -1.00 0.00 0.55
CD22 1,591 Target Disease Infertility 35,448 1 0.00 -1.00 0.00 0.51
CD22 1,591 Target Target CD72 198 29 0.05 -0.92 0.15 0.77
CD22 1,591 Target Disease Malnutrition 27,452 1 0.00 -1.00 0.00 0.52
CD22 1,591 Target Disease Mesothelioma 11,198 2 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Warts 5,574 1 0.00 -1.00 0.00 0.56
CD22 1,591 Target Disease Urticaria 10,717 1 0.00 -1.00 0.00 0.54
Maternal Embryonic Leucine Zipper Kinase 39 Target Target CCNB1 160 1 0.01 -0.98 0.03 0.74
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Cancer 1,053,491 21 0.00 -0.68 0.54 0.58
Maternal Embryonic Leucine Zipper Kinase 39 Target Target Calmodulin 25,240 1 0.00 -0.99 0.03 0.59
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Fracture 111,575 1 0.00 -0.99 0.03 0.56
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Prostate Cancer 71,064 1 0.00 -0.99 0.03 0.57
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Osteoporosis 46,215 1 0.00 -0.99 0.03 0.58
Maternal Embryonic Leucine Zipper Kinase 39 Target Target CHK2 1,391 1 0.00 -0.99 0.03 0.67
Maternal Embryonic Leucine Zipper Kinase 39 Target Target ERBB4 994 1 0.01 -0.99 0.03 0.68
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Dementia 66,782 1 0.00 -0.99 0.03 0.57
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Breast Cancer 173,695 6 0.00 -0.92 0.15 0.59
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Brain Tumors 16,749 7 0.01 -0.91 0.18 0.65
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Glioblastoma 17,933 10 0.01 -0.86 0.26 0.66
Glutathione Transferase Omega-1 14 Target Disease Hypoglycemia 20,698 1 0.00 -0.96 0.07 0.61
Glutathione Transferase Omega-1 14 Target Disease Cancer 1,053,491 6 0.00 -0.76 0.43 0.57
Glutathione Transferase Omega-1 14 Target Disease Ovarian Cancer 33,996 1 0.00 -0.96 0.07 0.60
Glutathione Transferase Omega-1 14 Target Disease Hyperglycemia 28,168 1 0.00 -0.96 0.07 0.61
Glutathione Transferase Omega-1 14 Target Target ERK1 18,374 2 0.00 -0.93 0.14 0.63
Glutathione Transferase Omega-1 14 Target Target Collagen 138,882 1 0.00 -0.96 0.07 0.57
Glutathione Transferase Omega-1 14 Target Disease Diabetic Retinopathy 14,494 1 0.00 -0.96 0.07 0.62
Glutathione Transferase Omega-1 14 Target Disease Breast Cancer 173,695 3 0.00 -0.89 0.21 0.59
Glutathione Transferase Omega-1 14 Target Target Glutathione Peroxidase 3 132 1 0.02 -0.96 0.07 0.76
Glutathione Transferase Omega-1 14 Target Disease Inflammation 252,734 1 0.00 -0.96 0.07 0.56
ANXA7 35 Target Target Epidermal Growth Factor Receptor 24,772 1 0.00 -0.99 0.03 0.60
ANXA7 35 Target Disease Seizure 44,685 1 0.00 -0.99 0.03 0.58
ANXA7 35 Target Disease Diabetes 332,602 1 0.00 -0.99 0.03 0.54
ANXA7 35 Target Disease Carcinoma 433,099 3 0.00 -0.96 0.09 0.56
ANXA7 35 Target Target ASK1 762 1 0.01 -0.98 0.03 0.69
ANXA7 35 Target Disease Cancer 1,053,491 15 0.00 -0.76 0.43 0.57
ANXA7 35 Target Target Calmodulin 25,240 1 0.00 -0.99 0.03 0.59
ANXA7 35 Target Disease Prostate Cancer 71,064 7 0.00 -0.89 0.20 0.62
ANXA7 35 Target Disease Schizophrenia 77,034 1 0.00 -0.99 0.03 0.57
ANXA7 35 Target Disease Shock 134,031 2 0.00 -0.97 0.06 0.57
ANXA7 35 Target Target DAPK1 205 1 0.01 -0.98 0.03 0.74
ANXA7 35 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.99 0.03 0.61
ANXA7 35 Target Disease Anemia 81,663 1 0.00 -0.99 0.03 0.57
ANXA7 35 Target Target Adenosine Deaminase 6,613 1 0.00 -0.99 0.03 0.63
ANXA7 35 Target Target APOE 12,771 1 0.00 -0.99 0.03 0.61
ANXA7 35 Target Disease Epilepsy 71,172 1 0.00 -0.99 0.03 0.57
ANXA7 35 Target Target EPHB2 385 1 0.01 -0.98 0.03 0.71
ANXA7 35 Target Target Collagen 138,882 1 0.00 -0.99 0.03 0.56
ANXA7 35 Target Disease Dyslipidemia 15,225 1 0.00 -0.99 0.03 0.61
ANXA7 35 Target Target EGF 27,487 1 0.00 -0.99 0.03 0.59
ANXA7 35 Target Disease Leukemia 162,805 1 0.00 -0.99 0.03 0.55
ANXA7 35 Target Disease Breast Cancer 173,695 2 0.00 -0.97 0.06 0.57
ANXA7 35 Target Disease Brain Tumors 16,749 3 0.00 -0.96 0.09 0.63
ANXA7 35 Target Target BDNF 11,163 1 0.00 -0.99 0.03 0.61
ANXA7 35 Target Disease Glioblastoma 17,933 5 0.01 -0.93 0.14 0.64
Epidermal Growth Factor Receptor 24,772 Target Disease Hypoglycemia 20,698 2 0.00 -1.00 0.00 0.47
Epidermal Growth Factor Receptor 24,772 Target Target CD1A 2,739 3 0.00 -1.00 0.00 0.54
Epidermal Growth Factor Receptor 24,772 Target Target CD68 6,424 18 0.00 -1.00 0.00 0.57
Epidermal Growth Factor Receptor 24,772 Target Target ATAC 239 7 0.00 -0.99 0.03 0.61
Epidermal Growth Factor Receptor 24,772 Target Disease Colon Cancer 30,064 383 0.01 -0.99 0.02 0.66
Epidermal Growth Factor Receptor 24,772 Target Disease Skin Disease 6,955 11 0.00 -1.00 0.00 0.55
Epidermal Growth Factor Receptor 24,772 Target Disease Meningitis 41,685 14 0.00 -1.00 0.00 0.51
Epidermal Growth Factor Receptor 24,772 Target Target CNTF 1,613 2 0.00 -1.00 0.00 0.54
Epidermal Growth Factor Receptor 24,772 Target Target Adenosine A3 Receptor 164 1 0.00 -1.00 0.01 0.57
Epidermal Growth Factor Receptor 24,772 Target Disease Lung Cancer 91,416 3,773 0.08 -0.90 0.15 0.72